1. Home
  2. PRAX vs MUSA Comparison

PRAX vs MUSA Comparison

Compare PRAX & MUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$299.14

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Murphy USA Inc.

MUSA

Murphy USA Inc.

HOLD

Current Price

$478.59

Market Cap

8.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
MUSA
Founded
2015
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.2B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
PRAX
MUSA
Price
$299.14
$478.59
Analyst Decision
Strong Buy
Buy
Analyst Count
15
7
Target Price
$572.13
$445.00
AVG Volume (30 Days)
309.6K
315.8K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
0.55%
EPS Growth
N/A
N/A
EPS
N/A
24.10
Revenue
N/A
$21,529,400,000.00
Revenue This Year
N/A
$17.24
Revenue Next Year
$6,395.88
$3.49
P/E Ratio
N/A
$19.24
Revenue Growth
N/A
N/A
52 Week Low
$26.70
$345.23
52 Week High
$354.87
$523.09

Technical Indicators

Market Signals
Indicator
PRAX
MUSA
Relative Strength Index (RSI) 43.28 74.22
Support Level $290.36 $386.86
Resistance Level $322.32 N/A
Average True Range (ATR) 16.93 18.16
MACD -3.50 6.05
Stochastic Oscillator 22.92 96.37

Price Performance

Historical Comparison
PRAX
MUSA

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About MUSA Murphy USA Inc.

Murphy USA Inc is mainly engaged in the marketing of retail motor fuel products and convenience merchandise through a network of several retail stores in the Southwest, Southeast, Midwest, and Northeast United States. The majority of Murphy USA's stores are located in proximity to Walmart Supercenters, but it also operates standalone stores that market gasoline and other products under the Murphy USA, Murphy Express, and QuickChek brands. In addition, the company also markets fuel to unbranded wholesale customers through a mixture of company-owned and third-party product distribution terminals and pipeline positions. The firm generates maximum revenue through retail sales of petroleum products, and the rest from merchandise sales and wholesale of petroleum products.

Share on Social Networks: